EMD-25736
HIV-1 Envelope ApexGT3.N130 in complex with PG9 Fab
EMD-25736
Single-particle4.75 Å
Deposition: 14/12/2021Map released: 28/09/2022
Last modified: 06/11/2024
Sample Organism:
Human immunodeficiency virus 1,
Homo sapiens
Sample: HIV-1 Envelope ApexGT3.N130 in complex with PG9 Fab
Fitted models: 7t77
Deposition Authors: Berndsen ZT, Ward AB
Sample: HIV-1 Envelope ApexGT3.N130 in complex with PG9 Fab
Fitted models: 7t77
Deposition Authors: Berndsen ZT, Ward AB
Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors.
Willis JR,
Berndsen ZT,
Ma KM,
Steichen JM,
Schiffner T ,
Landais E,
Liguori A,
Kalyuzhniy O,
Allen JD ,
Baboo S ,
Omorodion O ,
Diedrich JK,
Hu X,
Georgeson E,
Phelps N,
Eskandarzadeh S,
Groschel B,
Kubitz M,
Adachi Y,
Mullin TM,
Alavi NB,
Falcone S,
Himansu S ,
Carfi A,
Wilson IA,
Yates 3rd JR,
Paulson JC,
Crispin M ,
Ward AB ,
Schief WR
(2022) Immunity , 55 , 2149
,
Landais E,
Liguori A,
Kalyuzhniy O,
Allen JD ,
Baboo S ,
Omorodion O ,
Diedrich JK,
Hu X,
Georgeson E,
Phelps N,
Eskandarzadeh S,
Groschel B,
Kubitz M,
Adachi Y,
Mullin TM,
Alavi NB,
Falcone S,
Himansu S ,
Carfi A,
Wilson IA,
Yates 3rd JR,
Paulson JC,
Crispin M ,
Ward AB ,
Schief WR
(2022) Immunity , 55 , 2149
Grant Support:
- Bill & Melinda Gates Foundation: OPP1084519 (United States)
- Bill & Melinda Gates Foundation: OPP1196345 (United States)
- National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID): UM1 Al100663 (United States)
- National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID): UM1 AI144462 (United States)